Skip Navigation



NDT Advance Access published online on July 30, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn421
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/1/272    most recent
gfn421v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kolesnyk, I.
Right arrow Articles by Krediet, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolesnyk, I.
Right arrow Articles by Krediet, R. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients

Inna Kolesnyk1, Marlies Noordzij2, Friedo W. Dekker3, Elisabeth W. Boeschoten4 and Raymond T. Krediet1

1 Division of Nephrology, Department of Medicine 2 Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre, University of Amsterdam 3 Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden 4 Hans Mak Institute, Naarden, the Netherlands

Correspondence and offprint requests to: Inna Kolesnyk, Nephrology Division, Secretariat of Dialysis Department A01-114, AMC, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands. Tel: +31-20-566-6137; Fax: +31-20-691-4904; E-mail: i.kolesnyk{at}amc.uva.nl



  Abstract

Background. Experimental studies showed that inhibition of AII effects attenuates the development of peritoneal membrane fibrosis and neoangiogenesis. The latter leads to an increase of peritoneal solute transport and ultrafiltration failure. The results of a single-centre study showed that use of ACEI/ARB can prevent the increase of small solute transport in long-term PD patients. Our aim was to investigate whether these results would also be present in a larger population and influence patient and technique survival in long-term PD.

Methods. We analysed data from 217 long-term CAPD patients, participating in the Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Included patients underwent CAPD therapy for at least 2 years; 120 of them were treated with the ACE/AII inhibitors-ACEI/ARB group. The control group consisted of 87 patients who received none of the above drugs and 10 patients who had them for <25% of their time on PD.

Results. A significant difference in the time course of peritoneal transport was found between the two groups. The value of 24-h D/P creatinine was associated with the PD duration (P = 0.01) and its time course was influenced by use of ACEI/ARB (P = 0.05). We found no effect of ACEI/ARB on patient survival, but some benefit was found for the technique survival: in a multivariate model the hazard ratio for the group with the longest use of ACEI/ARB was 0.5 (CI 0.22–1.4), P = 0.19.

Conclusions. We conclude that AII inhibition prevents the increase in small solute transport in long-term PD. These drugs may also have some positive influence on PD technique survival.

Keywords: ACE inhibitors; angiotensin II receptor blockers; peritoneal dialysis; technique survival; transport

Received for publication: 22. 1.08
Accepted in revised form: 3. 7.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.